What is the current Price Target for the Soleno Therapeutics Inc stock?

The average Soleno Therapeutics Inc target price is $99.78. This is 38.27% higher than the current stock price. The highest price target is 70.45%, the lowest is 12.25%. 9 Analysts have issued a price target Soleno Therapeutics Inc 2026 .

How high will the Soleno Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Soleno Therapeutics Inc stock will rise. The performance of stocks, including the Soleno Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Soleno Therapeutics Inc stock today?

The performance of Soleno Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Soleno Therapeutics Inc stock fall?

The decline in Soleno Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Soleno Therapeutics Inc Forecast, price target & analysts

$68.94

4.46% today

Nasdaq, Apr 04, 07:48 pm CET

ISIN

US8342032005

Symbol

SLNO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Soleno Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Soleno Therapeutics Inc Classifications & Recommendation:

Buy

100%

Soleno Therapeutics Inc Price Target

Target Price	$99.78
Price	$72.16
Potential	38.27% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Soleno Therapeutics Inc 2026 . The average Soleno Therapeutics Inc target price is $99.78. This is 38.27% register free of charge higher than the current stock price. The highest price target is $123.00 70.45% register free of charge , the lowest is $81.00 12.25% register free of charge .
	A rating was issued by 9 analysts: 9 Analysts recommend Soleno Therapeutics Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Soleno Therapeutics Inc stock has an average upside potential 2026 of 38.27% register free of charge . Most analysts recommend the Soleno Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-4.38	-2.59
	85.59%	40.87%
P/E		negative
EV/Sales		82.71

2 Analysts have issued a Soleno Therapeutics Inc forecast for earnings per share. The average Soleno Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-4.38	85.59%
2025	$-2.59 40.87% Unlock
2026	$1.67 164.48% Unlock
2027	$4.24 153.89% Unlock
2028	$8.45 99.29% Unlock
2029	$12.86 52.19% Unlock

Current	-16.94	17.72%
2025	-27.91 64.76% Unlock
2026	43.34 255.28% Unlock
2027	17.02 60.73% Unlock
2028	8.54 49.82% Unlock
2029	5.61 34.31% Unlock

Soleno Therapeutics Inc...

Current Soleno Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 31 2025
Guggenheim	Locked ➜ Locked	Locked	Mar 28 2025
Stifel	Locked ➜ Locked	Locked	Mar 28 2025
Baird	Locked ➜ Locked	Locked	Mar 27 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Mar 27 2025
Laidlaw & Co.	Locked ➜ Locked	Locked	Mar 27 2025
Stifel	Locked ➜ Locked	Locked	Mar 05 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 31 2025
Locked Guggenheim: Locked ➜ Locked	Mar 28 2025
Locked Stifel: Locked ➜ Locked	Mar 28 2025
Locked Baird: Locked ➜ Locked	Mar 27 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Mar 27 2025
Locked Laidlaw & Co.: Locked ➜ Locked	Mar 27 2025
Locked Stifel: Locked ➜ Locked	Mar 05 2025

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now